16.30-17.00
devadmin2022-11-15T15:39:45+02:00Pharma - Kinevant Evaluation of an Anti-GM-CSF Monoclonal Antibody (Namilumab) in a Phase 2 Pulmonary Sarcoidosis Trial, Robert Baughman (USA), Kiyomi Komori (USA) Chairs: Irina Strâmbu (Romania)
17.00-18.30
admin2022-11-11T01:23:17+02:00Sarcoidosis 17.00 - Extrapulmonary sarcoidosis, Dan Culver (USA) 17.30 - Diagnosis: when biopsy is not needed, Robert Baughman (USA) 18.00 - New treatments in sarcoidosis, Robert Baughman (USA) Chairs: Irina Strâmbu (Romania), Katerina Antoniou (Greece)
14.30-16.00
admin2022-11-10T22:36:51+02:00Hypersensitivity pneumonitis 14.30 - Practical approach to diagnosis and treatment of HP in the light of new guidelines, Martina Koziar -Vasakova (Czech Republic) 15.00 - BAL in HP (and other ILDs), Ulrich Costabel (Germany) 15.30 - Occupational ILDs, Marina Oțelea (Romania) Chairs: Milena Man (Romania), Tudor Constantinescu (Romania)
13.30-14.30
admin2022-11-15T15:36:06+02:00Poster discussion Sarcoidosis Histochemical evaluation of 3 key inflammatory pathways in sarcoid granulomas, Raisa Kraaijvanger (The Netherlands) Quantitative Sensory Testing is Valuable for Diagnosing Sarcoidosis Associated Small Fiber Neuropathy, Lisette Raasing (The Netherlands) Pulmonary hypertension associated genetic variants in sarcoidosis associated pulmonary hypertension, Karlijn Groen (The Netherlands) Artificial Intelligence Enabled Electrocardiography Identifies Reduced Left Ventricular [...]
11.00-12.30
admin2022-11-10T22:33:11+02:00Sarcoidosis 11.00 - New guidelines in sarcoidosis, Irina Strâmbu (Romania) 11.30 - CT patterns in sarcoidosis, Helmut Prosch (Austria) 12.00 - Impact and limitations of sarcoidosis, Marjolein Drent (The Netherlands) Chairs: Jacob Sellares Torres (Spain), Diana Ioniță (Romania)
10.10-10.30
admin2022-11-10T22:31:11+02:00Pharma Astra Zeneca Re – evaluating mortality in COPD, Irina Strâmbu (Romania)
